AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Silence Therapeutics plc

Net Asset Value Jun 26, 2013

33536_agm-r_2013-06-26_2ccaed37-8a31-4183-9332-d02766aa6bc7.html

Net Asset Value

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9347H

Silence Therapeutics PLC

26 June 2013

RESULT OF AGM

26 June 2013

At the Company's annual general meeting held this morning all resolutions were passed, except for the re-appointment of David Mack as director, which was withdrawn following his resignation.

For further information please contact:

Silence Therapeutics

Ali Mortazavi, chief executive/Timothy Freeborn, finance director +44 (0)333 988 0140

[email protected]

[email protected]

N+1 Singer

Shaun Dobson/Jenny Wyllie

+44 20 7496 3000

[email protected]

[email protected]

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGSEIFDMFDSELM

Talk to a Data Expert

Have a question? We'll get back to you promptly.